Dr. Harb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Union Rd
West Seneca, NY 14224Phone+1 716-674-5138
Education & Training
American University of Beirut Faculty of MedicineClass of 1982
Certifications & Licensure
NJ State Medical License 1994 - 2025
NY State Medical License 1980 - 2025
FL State Medical License 1995 - 2004
PA State Medical License 1993 - 2000
Clinical Trials
- Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase for Infants and Children Start of enrollment: 2007 Aug 01
- Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration Start of enrollment: 2007 Jun 01
Publications & Presentations
PubMed
- 663 citationsPeginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.Raymond T. Chung, Janet Andersen, Paul A. Volberding, Gregory K. Robbins, Tun Liu
The New England Journal of Medicine. 2004-07-29 - 23 citationsProlonged survival of microencapsulated neonatal porcine islets in mice treated with a combination of anti-CD154 and anti-LFA-1 monoclonal antibodies.Tsunehiro Kobayashi, George Harb, Gina R. Rayat
Transplantation. 2005-09-27 - 45 citationsSafety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administr...George Harb, Francois Lebel, Jean P. Battikha, Jeffrey W Thackara
Current Medical Research and Opinion. 2010-01-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
